Insiders Sanofi

Stocks

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-17 am EDT			5-day change	1st Jan Change
77.34 ^EUR	+0.52%		+1.46%	-6.50%

Jul. 17	Sanofi strengthens its research alliance with Aqemia
Jul. 17	Aqemia and Sanofi Expand Research Collaboration	CI

Insiders

Jun. 22	Sanofi Announces Appointment of Paulo Fontoura to Executive Vice President, Global Head of Research & Development Pharma and Executive Committee, Effective September 1, 2026	CI
Apr. 29	Sanofi Announces Board and Committee Changes	CI
Apr. 07	Sanofi: Treatment for re-rating isn’t easy
Mar. 05	Sanofi Announces Resignation of Patrick Kron as Independent Director and Chairman of the Nomination, Governance and Csr Committee	CI
Feb. 24	Alveus Therapeutics, Inc. announced that it has received $197 million in funding from a group of investors	CI
Feb. 17	Sanofi Announces Executive Changes	CI
Feb. 17	Sanofi appoints Manuela Buxo as head of specialty care	RE
Feb. 12	PRESS DIGEST-Financial Times - February 13	RE
Feb. 12	Jefferies Identifies the Key Challenge for Sanofi's New CEO
Feb. 12	Sanofi Shares Fall After CEO Change	DJ
Feb. 12	Sanofi Announces Chief Executive Officer Changes	CI
Feb. 12	The Pill Is Hard to Swallow for Investors
Feb. 12	Sanofi Names Belen Garijo as Chief Executive	MT
Feb. 12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
Feb. 12	Belén Garijo to become chief executive officer of Sanofi	RE
Feb. 12	Sanofi appoints Belén Garijo as new CEO after deciding not to renew current CEO Hudson's mandate	RE
Feb. 12	Sanofi Names Merck KGaA's Belen Garijo to Replace Paul Hudson as CEO -- Update	DJ
Feb. 12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
Feb. 12	Sanofi Names Belen Garijo to Replace Paul Hudson as CEO	DJ
Feb. 12	Sanofi Appoints Former Merck KGaA Executive as New CEO	MT
Feb. 12	Belén Garijo to Replace Paul Hudson as Head of Sanofi
Jan. 08	Alveus Therapeutics ApS announced that it has received $159.8 million in funding from New Rhein Healthcare Investors, LLC, Andera Partners, Omega Fund Management, LLC, Kurma Partners SA, Avego BioScience Capital, Sanofi and other investors	CI
Jan. 07	Alveus Therapeutics, Inc. amended terms of the transaction	CI
25-10-08	Biovaxys appoints former Sanofi Vaccines executive to board of directors	RE
25-07-01	Sanofi: Pipeline disappointments may push out the CEO